Table 4. The desired target range of Tac concentration, the predicted daily dosage range and the observed daily dose of Tac in overall (n=231) and CYP3A5*3/*3 subjects (n=173). Mean±SD.
Subjects | Desired target range of concentration (ng·mL−1)a | Predicted daily dosage range (mg·d−1) |
Observed daily dose (mg·d−1) | |
---|---|---|---|---|
Lower bound | Upper bound | |||
Overall | 3–7 | 1.0±0.4 | 3.7±1.5 | 3.4±1.5 |
CYP3A5*3/*3 genotype | 3–7 | 0.9±0.4 | 3.2±1.6 | 3.1±1.5 |
aThe desired target range of concentration was set according to the clinical practice in the 3rd Affiliated Hospital of Xiangya Medical Institute, Central South University;